Abstract:33 patients with drug‐resistant epilepsy were treated with VNS and followed‐up up to 5 years. Patients were evaluated with the maze, interference and written verbal fluency tests as a part of EpiTrack screening before and after VNS implantation through repeated follow‐ups. The results showed that visual anticipation and planning improved significantly on a group level during follow‐up, with marked enhancements observed in DRE patients with psychiatric comorbidities during VNS therapy. Patients with frontal lobe epilepsy and those taking fewer than three ASMs improved significantly in response inhibition. Background The effect of vagus nerve stimulation (VNS) on cognitive domain of attention and executive functions (AEFs) has not been extensively researched. This study was set up to investigate performance variability on cognitive tests assessing AEFs in drug‐resistant epilepsy (DRE) patients receiving VNS therapy during a follow‐up of up to 5 years. Methods Thirty‐three DRE patients were assessed with the interference, maze, and written verbal fluency tests as a part of EpiTrack screening before and after VNS implantation through repeated follow‐ups according to the clinical VNS protocol. A linear mixed‐effects model was used to analyse changes in test scores. Results Maze performance improved significantly by an average of 0.20 s per month (95% confidence interval (CI): –0.365 to –0.041; p = 0.014). Interference performance improved by an average of 0.05 s per month (p = 0.207) and number of words increased by an average of 0.03 words per month (p = 0.079) on the verbal fluency test. On the maze test, patients with psychiatric comorbidities improved the most (0.52 s/month, p = 0.001), while on the interference test, patients with frontal lobe epilepsy (FLE), those taking 1–2 antiseizure medications (ASMs) and patients with focal to bilateral tonic–clonic seizures improved the most (0.14 s/month, p = 0.005; 0.14 s/month, p = 0.033 and 0.16 s/month, p = 0.087, respectively). For verbal fluency, no clinically meaningful improvement was noted in any of the groups. Conclusion During the follow‐up, maze performance markedly improved, while performance on the interference and verbal fluency tasks remained relatively stable at the group level. Accordingly, visual anticipation and planning improved during VNS therapy whereas response inhibition was unchanged at the group level despite significant enhancements in patients with FLE and those taking 1–2 ASM. Furthermore, the presence of psychiatric comorbidities correlated with even greater improvement on maze performance.

Long-term effects of vagus nerve stimulation on EEG aperiodic components in patients with drug-resistant epilepsy

A Prediction Model Integrating Synchronization Biomarkers and Clinical Features to Identify Responders to Vagus Nerve Stimulation among Pediatric Patients with Drug-Resistant Epilepsy.

Long-term Effect of Vagus Nerve Stimulation on Interictal Epileptiform Discharges in Refractory Epilepsy

Predictors of Seizure Reduction Outcome after Vagus Nerve Stimulation in Drug-Resistant Epilepsy

Altered amplitude of low-frequency fluctuations and regional homogeneity in drug-resistant epilepsy patients with vagal nerve stimulators under different current intensity

Efficacy and Potential Predictors of Vagus Nerve Stimulation Therapy in Refractory Postencephalitic Epilepsy.

Immediate Effects of Vagal Nerve Stimulation in Drug-Resistant Epilepsy Revealed by Magnetoencephalographic Recordings

A resting-state functional MRI study on the effect of vagal nerve stimulation on spontaneous regional brain activity in drug-resistant epilepsy patients

Efficacy analysis of vagus nerve stimulation for the treatment of drug resistant epilepsy: A report of 110 cases

Vagus nerve stimulation for treating developmental and epileptic encephalopathy in young children

Acute Effect of Vagus Nerve Stimulation in Patients with Drug-Resistant Epilepsy: A Preliminary Exploration Via Stereoelectroencephalogram.

Epilepsy duration as an independent predictor of response to vagus nerve stimulation

Characterization of Vagus Nerve Stimulation (VNS) Dose-Dependent Effects on EEG Power Spectrum and Synchronization

Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex

Vagus Nerve Stimulation Therapy For The Treatment Of Seizures In Refractory Postencephalitic Epilepsy: A Retrospective Study

Effects of Stable Vagus Nerve Stimulation Efficacy on Autistic Behaviors in Ten Pediatric Patients With Drug Resistant Epilepsy: An Observational Study

Long-term outcomes and prognosis factors of vagus nerve stimulation in patients with refractory epilepsy

Preoperative Heart Rate Variability as Predictors of Vagus Nerve Stimulation Outcome in Patients with Drug-resistant Epilepsy

A predictive model combining connectomics and entropy biomarkers to discriminate long‐term vagus nerve stimulation efficacy for pediatric patients with drug‐resistant epilepsy

Retention rate of vagus nerve stimulation for the treatment of drug-resistant epilepsy: a single-centre, retrospective study.

Changes in Response Inhibition, Visual Anticipation and Verbal Fluency During Vagus Nerve Stimulation Therapy in Patients With Drug‐Resistant Epilepsy